Clinical Trial Update: Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating autologous lung stem cell transplantation for interstitial lung diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• Autologous lung stem cell transplantation

Snippet

Sponsor: Shanghai East Hospital | Conditions: Interstitial Lung Diseases | Phase 1, Phase 2 | Status: COMPLETED